A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC).

Ezanno, Anne-Cecile; Malgras, Brice; Aoun, Olivier; Delarge, Amaury; Doreille, Alice; Pocard, Marc

Ezanno, Anne-Cecile; Malgras, Brice; Aoun, Olivier; Delarge, Amaury; Doreille, Alice; Pocard, Marc.

Afiliación

Ezanno AC; Department of Gastrointestinal and Endocrine Surgery, Bégin Military Hospital, St Mandé, France.
Malgras B; Department of Gastrointestinal and Endocrine Surgery, Bégin Military Hospital, St Mandé, France.
Aoun O; 46th Medical Unit, 5th Armed Forces Medical Center, Strasbourg, France.
Delarge A; Department of Acute Care Unit, Bégin Military Hospital, St Mandé, France.
Doreille A; Department of Nephrology, Tenon Hospital, Paris, France.
Pocard M; Department of Gastrointestinal and Cancerology, Pitié Salpetrière Hospital, Paris, France.

Pleura Peritoneum ; 7(1): 35-38, 2022 Mar 01.

Article en En | MEDLINE | ID: mdl-35602921

Palabras clave

PIPAC; colorectal cancer; drug reaction; hypersensitivity reaction; oxaliplatin; oxaliplatin immune-induced syndrome (OIIS)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pleura Peritoneum Año: 2022 Tipo del documento: Article País de afiliación: Francia